Skip to main content
Cardiovascular Disease Epidemiology Training Program


Faculty Advisors, Title, Primary Appointment (Joint Appointment) — Cardiovascular Disease Interests


Josef Coresh, (PI) MD, PhD, Program Director — Cardiovascular and kidney disease, epidemiologic methods, genetic epidemiology

Elizabeth Selvin, PhD, MPH, Program Co-Director— Cardiovascular disease and diabetes, epidemiologic methods, biomarkers of diabetes and hyperglycemia

Shoshana H. Ballew, PhD, Assistant Program Director— Aging, caregiving, epidemiology, chronic kidney disease, cardiovascular disease

Lawrence J. Appel, MD, MPH — Blood pressure-related cardiovascular and kidney diseases, nutrition

Terri H. Beaty, MA, PhD — Use of statistical genetics to identify genetic factors contributing to risk of chronic diseases

Michael J. Blaha, MD, MPH — Primary Prevention of Heart Disease and Stroke; Advanced Subclinical Atherosclerosis

Lorraine T. Dean, ScD — Social determinants, cancer survivorship, HIV/AIDS, disparities

Mara M. DeMarco, PhD — Epidemiology of aging, end stage renal disease, pharmacoepidemiology, gout

Rebecca Gottesman, MD, PhD — Improving functional outcome scales after stroke epidemiology and clinical research. Vascular basis of dementia.  Neurological aspects of CVD and development of stroke after cardiac surgery

Morgan Grams, MD — Chronic kidney disease, pharmacoepidemiology, omics studies

Eliseo Guallar, MD, DrPH — Cardiovascular epidemiology, with a special emphasis on Environmental exposures such as heavy metals. Epidemiologic methods especially meta-analysis

John W. Jackson, ScD — Causal inference, confounding, decomposition, epidemiology, health disparities, instrumental variable, interaction, intersectionality, mediation-analysis, mental health, meta-analysis, pharmacoepidemiology, psychotropics, diagnostics, observational-study, time-varying exposure, translational research, transparency

Seth S. Martin, MD, MHS — Cardiovascular Risk Assessment, Dyslipidemia, Mobile Health Technology, Primary and secondary prevention of coronary heart disease, Individuals with a family history of heart disease, Improved strategies for management of cardiovascular risk factors, Preventive Cardiology, Atherosclerosis Imaging, Lipids.  Co-leads a Strategically Focused Health Technologies & Innovation Research Network Award funded by the AHA and the Center for Health Technology and Innovation.

Kunihiro Matsushita, MD, PhD — Cardiovascular disease epidemiology, especially heart failure, peripheral arterial disease, chronic kidney disease. Meta-analysis and risk prediction methods

Erin D. Michos, MD, MHS, FACC, FAHA — Women and heart disease, vitamin D and cardiovascular health, preventive cardiology, subclinical atherosclerosis imaging, sex hormones and cardiovascular disease

Noel T. Mueller, PhD, MPH, FAHA — Epidemiology, nutrition, microbiome, obesity, type 2 diabetes, non-alcoholic fatty liver disease

Chiadi E. Ndumele, MD, MHS, PhD - Obesity and its metabolic and cardiovascular consequences. Co-leads a Strategically Focused Cardiometabolic Health & Type 2 Diabetes Mellitus Research Network – Award from AHA.

Wendy Post, MD — Risk prediction, cardiovascular disease in HIV, subclinical atherosclerosis imaging, genetic epidemiology

Tanjala S. Purnell, PhD, MPH — Improved equity in access to kidney transplantation, reduced disparities in kidney disease burden and outcomes, patient-centered care for kidney disease and risk factors, including hypertension and diabetes, community and stakeholder-engaged interventions

Debashree Ray, PhD — Case-control study, external controls, Genome-wide association study (GWAS), lipids, meta-analysis, multiple traits, multivariate analysis, overlapping samples, secondary traits, statistical genetics, statistical methods, trio study design, type II diabetes

Casey M. Rebholz, PhD — Biomarkers, kidney disease, cardiovascular disease, nutritional epidemiology

Jennifer A. Schrack, PhD — Epidemiological assessment of physical activity and fatigability, and their corresponding associations with health and longevity in older populations